Chris Tame
Company: Ternary Therapeutics
Job title: Chief Executive Officer
Seminars:
Leveraging Computational Approaches for the Discovery and Optimisation of Molecular Glues 1:00 pm
Evaluating the strengths and limitations of machine learning and molecular dynamics simulations for modelling ternary complexes in drug discovery Demonstrating how advanced computational platforms can enhance the discovery and optimisation of molecular glues, enabling more efficient development of targeted therapies Exploring the future potential of integrating computational techniques with experimental approaches to accelerate the development…Read more
day: Day 2, Track 1, PM